In the last trading session, 0.63 million Applied Therapeutics Inc (NASDAQ:APLT) shares changed hands as the company’s beta touched 1.82. With the company’s per share price at $6.75 changed hands at $0.0 or 0.00% during last session, the market valuation stood at $714.76M. APLT’s last price was a discount, traded about -39.11% off its 52-week high of $9.39. The share price had its 52-week low at $0.76, which suggests the last value was 88.74% up since then. When we look at Applied Therapeutics Inc’s average trading volume, we note the 10-day average is 1.14 million shares, with the 3-month average coming to 2.22 million.
Applied Therapeutics Inc (NASDAQ:APLT) trade information
With action 13.26%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 101.49%, with the 5-day performance at 13.26% in the green. However, in the 30-day time frame, Applied Therapeutics Inc (NASDAQ:APLT) is 17.60% up. Looking at the short shares, we see there were 4.33 million shares sold at short interest cover period of 1.44 days.
Applied Therapeutics Inc (APLT) estimates and forecasts
Data shows that the Applied Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 150.00% over the past 6 months, a 62.68% in annual growth rate that is considerably higher than the industry average of 12.20%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2024 revenue estimates. The rating firms predict current quarter revenue for Applied Therapeutics Inc will rise 33.30%, while the growth in revenue is estimated to hit 54.10% for the next quarter. Year-over-year growth is forecast to reach 7.20% up from the last financial year.
Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of $5 million. The company’s revenue for the corresponding quarters a year ago was $10.66 million. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -53.10%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -8.72%. The 2024 estimates are for Applied Therapeutics Inc earnings to increase by 52.74%.
APLT Dividends
Applied Therapeutics Inc is expected to release its next quarterly earnings report between May 09 and May 13.
Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 6.91% of Applied Therapeutics Inc shares while 69.56% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 74.72%. There are 69.56% institutions holding the Applied Therapeutics Inc stock share, with Franklin Resources, Inc. the top institutional holder. As of Jun 29, 2023, the company held 12.59% of the shares, roughly 7.95 million APLT shares worth $10.17 million.
VR Adviser, LLC holds the second largest percentage of outstanding shares, with 8.96% or 5.66 million shares worth $7.24 million as of Jun 29, 2023.
Among Mutual Funds, the top two as of Jul 30, 2023 were Franklin Strategic Series-Franklin Biotechnology Discove and Fidelity Select Portfolios – Biotechnology. With 3.4 million shares estimated at $6.05 million under it, the former controlled 5.38% of total outstanding shares. On the other hand, Fidelity Select Portfolios – Biotechnology held about 4.18% of the shares, roughly 2.64 million shares worth around $3.51 million.
